Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?
about
When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank.Dolutegravir-lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) studyElvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection.Mortality and survival patterns of people living with HIV-2How can we achieve universal access to low-cost treatment for HIV?Cost-effectiveness of routine viral load monitoring in low- and middle-income countries: a systematic review.Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?7-Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir.
P2860
Q33765196-14783BC7-08D2-4613-A013-4608B78ECAADQ38376451-05BDBB91-72C8-4BB6-93D8-5500C5BFDC19Q38836878-5F46D6B4-195A-42FE-865C-BEF28C3B88CAQ38851677-70623275-DC7B-47E5-947C-BA825DA8A7FAQ42380889-0FAB91D5-DC0C-4B76-A0CE-8C3D18D64F35Q47420352-7B3E901D-015B-4F0C-B52F-155CC857570AQ54230654-9BAC2161-AA65-41BA-AC62-503B9B288911Q55554218-1A71C10F-D65E-4199-A7D0-5A3D78FA2A2D
P2860
Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Choice of antiretroviral drugs ...... what more do we need to know?
@ast
Choice of antiretroviral drugs ...... what more do we need to know?
@en
type
label
Choice of antiretroviral drugs ...... what more do we need to know?
@ast
Choice of antiretroviral drugs ...... what more do we need to know?
@en
prefLabel
Choice of antiretroviral drugs ...... what more do we need to know?
@ast
Choice of antiretroviral drugs ...... what more do we need to know?
@en
P2093
P2860
P356
P1476
Choice of antiretroviral drugs ...... what more do we need to know?
@en
P2093
Andrew M Hill
Anton L Pozniak
Marco Vitoria
Meg Doherty
Nathan P Ford
P2860
P356
10.7448/IAS.19.1.20504
P50
P577
2016-02-02T00:00:00Z